Tag: MabPlex
MabPlex awards CloudWorks4All with Enterprise Resource Planning (ERP) Contract
MabPlex USA, the North American subsidiary, China-based MabPlex (Yantai, Shandong Province, China) has contracted systems integrator CloudWorks4All, a leading life science and cloud ERP...
MabPlex International Secures Series B Financing
MabPlex International, a Contract Development and Manufacturing Organization (CDMO) based in Yantai, the Shandong Peninsula in northeastern Shandong province, in China, confirmed that it...
How the Next Generation Antibody Drug Conjugates Expands Beyond Cytotoxic Payloads...
Antibody-drug Conjugates or ADCs combine the selectivity of antibodies with the efficacy of small molecule drugs, allowing for more precise, targeted, therapeutic applications.
Combining the...
MabPlex Launches Two New Cell Culture Production Lines and Plans Further...
MabPlex International, a fully integrated, Contract Development and Manufacturing Organization (CDMO) with sites in China (Yantai and Shanghai) and the United States (San Diego),...
Frost & Sullivan Awards MabPlex with the 2019 Global Growth Excellence...
Based on its recent analysis of the global contract manufacturing services market for antibody-drug conjugate or ADCs, Frost & Sullivan has awarded China-headquarter MabPlex...
Rapidly Expanding MabPlex International Secures U.S. $ 59.1 Million Series A...
In an announcement made to the international business and financial press, MabPlex International, a global Contract Development and Manufacturing Organization or CDMO based in...
MabPlex’s Manufactured Monoclonal Antibody Receives IND Approval from the U.S. Food...
Leading Contract Development and Manufacturing Organization (CDMO) MabPlex International, serving the global biopharmaceutical and biotechnology industries with sites in China and the United States,...
MabPlex Opens New Phase III and Commercial Manufacturing Facility
MabPlex International, a fully integrated Contract Development and Manufacturing Organization (CDMO) with sites in China and the United States, has inaugurated their new manufacturing...
Benefitting from the Worldwide Supply Chain in the development of Antibody-drug...
Timing is everything.
Just over a decade ago, the pharmaceutical industry and R&D in China was dominated by generics and plagued with insufficient technical capacity...
Researchers Develop Novel anti-CD19 Antibody-drug Conjugates for the Treatment of B-cell...
In an article published in July 2018 edition of the International Immunopharmacology researchers and scientists from RemeGen (Yantai 264006, Shandong, China) and Mabplex International...
